Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.8 USD | +9.38% | +9.38% | +18.64% |
Business Summary
Number of employees: 39
Sales per Business
USD in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
Glycomimetic Compounds
100.0
%
| 1 | 100.0 % | 0 | 100.0 % | -93.53% |
Sales per region
USD in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 1 | 100.0 % | 0 | 100.0 % | -93.53% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Harout Semerjian
CEO | Chief Executive Officer | 52 | 21-08-05 |
Rachel King
FOU | Founder | 64 | 03-04-03 |
Brian Hahn
DFI | Director of Finance/CFO | 49 | 10-01-31 |
Edwin Rock
CTO | Chief Tech/Sci/R&D Officer | 63 | 22-09-05 |
Deepak Tiwari
CTO | Chief Tech/Sci/R&D Officer | - | 22-03-01 |
Chinmaya Rath
PRN | Corporate Officer/Principal | 48 | - |
Bruce Johnson
PRN | Corporate Officer/Principal | 56 | 22-02-22 |
General Counsel | - | 19-04-28 | |
Comptroller/Controller/Auditor | 53 | 13-12-31 | |
Lisa V. DeLuca
LAW | General Counsel | - | 21-11-21 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Daniel Junius
BRD | Director/Board Member | 71 | 16-03-16 |
Patricia Andrews
BRD | Director/Board Member | 66 | 17-06-11 |
Scott Jackson
BRD | Director/Board Member | 59 | 18-11-27 |
Rachel King
FOU | Founder | 64 | 03-04-03 |
Scott Koenig
BRD | Director/Board Member | 71 | 17-03-12 |
Timothy Pearson
CHM | Chairman | 56 | 14-03-30 |
Mark Goldberg
BRD | Director/Board Member | 69 | 14-07-09 |
Harout Semerjian
CEO | Chief Executive Officer | 52 | 21-08-05 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 64,393,294 | 62,467,995 ( 97.01 %) | 0 | 97.01 % |
Company contact information
GlycoMimetics, Inc.
9708 Medical Center Drive
20850, Rockville
+240 243 1201
http://www.glycomimetics.comSector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+18.64% | 165M | |
+1.10% | 105B | |
+9.29% | 104B | |
-3.00% | 22.09B | |
-11.89% | 21.98B | |
-26.59% | 20.17B | |
-5.20% | 19.49B | |
-6.58% | 17.75B | |
+5.83% | 13.84B | |
+7.46% | 11.64B |
- Stock
- Equities
- Stock GlycoMimetics, Inc. - Nasdaq
- Company GlycoMimetics, Inc.